Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Walsall Hospitals NHS Trust Goes Live With Horizon Enterprise Visibility From Mckesson, UK
Walsall Hospitals NHS Trust has "gone-live" with Horizon Enterprise Visibility; a visual control system designed specifically for hospitals, from healthcare IT solutions and services specialists, McKesson. Via real-time access to patient information, Walsall will be using Horizon Enterprise Visibility to improve re efficiency and bed utilisation to reduce costs and improve the quality of patient care.
generic viagra online
Also In Global Health News: HIV Aid For Vietnam; Gates To Meet With WHO; Women's Health In Philippines; Zambian Health Workers; HIV In Ghana
U.K. Pledges $30M To Vietnam HIV/AIDS Efforts
News of the day
Alexion's Soliris(R) Receives 2009 Prix Galien France For Most Innovative Drug For Rare Disease
Alexion Pharma France and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today received the 2009 Prix Galien France for Soliris® (eculizumab) in the category of medicines for rare diseases. The award recognizes the scientific innovation represented by the complement-inhibition technology of Soliris, and the impact the drug is having on the lives of patients with paroxysmal nocturnal hemoglobinuria (PNH), an ultra-rare, debilitating and life-threatening blood disorder.
Health Insurance

Scientists Examine HIV's Effect On Immune System

A study by researchers from Duke University and the University of North Carolina-Chapel Hill and published in PLoS Medicine has found that upon infection "three lines of attack by the immune system are quickly neutralized by HIV," findings they hope "will provide a better understanding of how to develop a vaccine to protect against the virus," the Raleigh News & Observer reports. The study, lead by Duke"s Barton Haynes, showed that HIV, "once considered a slow if stealthy invader, actually works incredibly fast at disarming key immune fighters in the body." Haynes said scientists still have a difficult task in developing a vaccine, adding, "It would have to be different than any other vaccine made" (Avery, 7/7). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009